SPRTN and TDP1/TDP2 Independently Suppress 5-Aza-2'-deoxycytidine-Induced Genomic Instability in Human TK6 Cell Line

Toshiaki Nakano1, Takahito Moriwaki2, Masataka Tsuda3

  • 1DNA Damage Chemistry Research Group, Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, Kizugawa, Kyoto 619-0215, Japan.

Insights

The metalloprotease SPRTN protects cells from DNA-protein cross-links (DPCs) caused by 5-aza-2'-deoxycytidine (5-azadC). SPRTN deficiency increases sensitivity to 5-azadC, highlighting its role in repairing DNMT1-DPCs and preventing genome instability.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • DNA-protein cross-links (DPCs) are harmful DNA adducts formed by endogenous and exogenous agents.
  • 5-aza-2'-deoxycytidine (5-azadC) forms DNA methyltransferase 1 (DNMT1)-DPCs during DNA replication.
  • The repair mechanisms for DNMT1-DPCs remain incompletely understood.

Purpose of the Study:

  • To investigate the role of the metalloprotease SPRTN in the repair of 5-azadC-induced DNMT1-DPCs.
  • To explore the involvement of other DNA repair pathways, such as TDP1 and TDP2, in response to DNMT1-DPCs.
  • To elucidate the contribution of SPRTN and TDP1/TDP2 to cellular resistance against 5-azadC.

Main Methods:

  • Utilized SPRTN-deficient (SPRTN-/-) and wild-type human TK6 cells.
  • Assessed cellular sensitivity and DNMT1-DPC removal rates following 5-azadC treatment.
  • Investigated the role of ubiquitination-dependent proteasomal degradation.
  • Examined chromosomal breaks in SPRTN-/- and TDP1-/-TDP2-/- cells.

Main Results:

  • SPRTN-deficient cells exhibited heightened sensitivity to 5-azadC and slower DNMT1-DPC removal.
  • Ubiquitination-dependent proteasomal degradation contributed to DNMT1-DPC repair independently of SPRTN.
  • Cells deficient in both TDP1 and TDP2 (TDP1-/-TDP2-/-) also showed sensitivity to 5-azadC.
  • 5-azadC treatment led to significant chromosomal breaks in SPRTN-/- and TDP1-/-TDP2-/- cells compared to wild-type.

Conclusions:

  • SPRTN plays a crucial role in protecting cells against 5-azadC-induced DNMT1-DPCs, likely through direct proteolytic processing.
  • TDP1 and TDP2 contribute to suppressing genome instability arising from 5-azadC-induced DNMT1-DPCs.
  • The combined action of SPRTN and TDP1/TDP2 is essential for maintaining genomic integrity in the presence of DNMT1-DPCs.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.6K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K